Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacyJian Xu, Yong‐Su Zhen, Shenghua Zhang et al.|Pharmacological Research|2017Cited by 31
EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosisWenjuan Liu, Yong‐Su Zhen, Xiujun Liu et al.|Acta Pharmacologica Sinica|2018Cited by 25